Hans-Peter Landolt: Clinical Trials

2 trials sponsored by Hans-Peter Landolt, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Recruiting 1

Follow Hans-Peter Landolt: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of the LC-NA System in Experimental Sleep Fragmentation
DMTN, Auditory Stimulation, Placbo - The Role of the LC-NA System in Sleep Regulation
Phase 1RecruitingHans-Peter Landolt422026-05-212026-06-12
A Causal Role for Voltage-gated Cav1.2 Calcium Channels in Mediating 5G FR1 Effects on Sleep-associated Brain Health in Humans
Nimodipine Capsules, 5G RF-EMF - Mediation of 5G Effects on Sleep
Not applicableRecruitingHans-Peter Landolt302024-10-222025-05-31

Conditions studied

Parasomnias (1)

Interventions

Acoustic Stimulation (1)  ·  Nimodipine (1)

Countries

Switzerland (2)

NIH funding

2025 (1)